Beta Estimation With Stock Return Outliers: The Case of U.S. Pharmaceutical Companies

SSRN Electronic Journal
doi 10.2139/ssrn.1410371
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV


Related search